Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 07, 2015 2:01 AM ET


Company Overview of Samsung Biologics Co., Ltd.

Company Overview

Samsung Biologics Co., Ltd. develops and manufactures biological products through genetic engineering, cell culture technology, purification, and fill and finish technology. It focuses on offering biologics development and manufacturing solutions for the manufacture of therapeutic proteins. The company provides process development services, including cell line development programs, and upstream and downstream process development services. It also provides contract management services that comprise cGMP manufacturing programs for cell line development, process and analytical development, clinical phase I/II/III manufacturing, full-scale commercial manufacturing, and aseptic fill and finish op...

125, Cheomdan-daero


Incheon,  406-840

South Korea

Founded in 2011


82 0 455 3300


82 0 455 3322

Key Executives for Samsung Biologics Co., Ltd.

Chief Executive Officer, President and Director
Vice President of Corporate Business Operation
Chief Information Officer and Vice President
Executive Vice President and Director
Executive Director
Compensation as of Fiscal Year 2014.

Samsung Biologics Co., Ltd. Key Developments

Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM

Samsung Biologics Co., Ltd. Presents at BIO International Convention, Jun-25-2014 03:15 PM. Venue: San Diego Convention Center, San Diego, California, United States.

Samsung Biologics Announces the Expansion of Existing Manufacturing Agreement with Bristol-Myers Squibb

Samsung BioLogics has announced that it has expanded its existing manufacturing agreement with Bristol-Myers Squibb. BMS's president of Global Manufacturing & Supply noted that the expanded agreement, will give the company flexibility to respond to increased demand in order to meet the global needs of patients. Details of which products will be covered by the deal or financial considerations have not yet been disclosed.

Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site. Financial terms of the agreement are not disclosed. Bristol-Myers Squibb and Samsung announced their first manufacturing agreement in July 2013 to collaborate in the production of a single commercial antibody cancer drug substance.

Similar Private Companies By Industry

Company Name Region
Histostem Co., Ltd. Asia
Micro Science Tech Co., Ltd. Asia
GenoCheck Co.,Ltd. Asia
Nanobiosys Inc. Asia
Bioceltran Co., Ltd Asia

Recent Private Companies Transactions

Private Placement
February 5, 2015
Private Placement
July 11, 2014
Samsung Bioepis Co., Ltd.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Samsung Biologics Co., Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at